1.Esophageal ulceration induced by zidovudine in a patient with AIDS.
Dong Ho NAM ; Joon Myung KIM ; Jae Yoon JUN ; Chun Soo HONG
Korean Journal of Infectious Diseases 1993;25(3):249-252
No abstract available.
Humans
;
Ulcer*
;
Zidovudine*
2.Change of serum ?-microglobulin, p24 antigen and CD4+ T lymphocyte in persons with human immunodeficiency virus infection after azidothymidine treatment.
Yung Kul CHO ; Yoo Kyum KIM ; Yung Oh SHIN ; Yang Ja CHO
Korean Journal of Infectious Diseases 1993;25(3):211-220
No abstract available.
HIV*
;
Humans
;
Humans*
;
Lymphocytes*
;
Zidovudine*
3.Detection of Mutations to Zidovudine in the pol Gene of Human Immunodeficiency Virus-1 by Direct Sequencing.
Young Keol CHO ; Hee Jung LEE ; Heung Sup SUNG ; Yoo Kyum KIM ; Young Bong KIM ; Yongjin LEE ; Mi Jung KIM ; Dae Ghon KIM ; Young Ho WON ; Goon Jae CHO
Journal of the Korean Society of Virology 1999;29(4):271-281
No abstract available.
Genes, pol*
;
HIV-1
;
Humans*
;
RNA-Directed DNA Polymerase
;
Zidovudine*
4.Effect of GCV on Neuroblastoma Cell Line Expressed by HSV-TK Gene with Retroviral Vector.
Hyun Sang CHO ; Chuhl Joo LYU ; Yeun Soo KIM ; Tae Soo KIM ; Byung Soo KIM
Journal of the Korean Pediatric Society 1997;40(12):1719-1724
Background : Gene transfer with vectors derived from murine retroviruses is restricted to cells which are proliferating and synthesizing DNA at the time of infection. Accordingly, selective introduction of genes encoding for susceptibility to otherwise nontoxic drugs (suicide genes) into proliferating tumor may be used to treat cancer. We investigated the efficacy of in vitro transduction of neuroblastoma cell with the herpes simplex-thymidine kinase (HSV-tk) gene followed by administration of the antiviral drug ganciclovir. METHODS: The LNC/tK vector was transfered in vitro into mouse Neuro 2a cell lines (ATCC) and the transduced cell lines were selected in G-418, 500microgram/ml, for 14 days. Onex104 cells were cultured in 96 well culture plates in increasing concentrations of ganciclovir for 72 hours. The sesitivity to ganciclivir of these HSV-tk transduced, G-418 selected cells was measured with MTT assay RESULTS: The survival of HSV-tk transduced 1x104 neuro 2a cell lines is 103+/-3.5%, 68+/-4.2%, 54+/-3.8%, 17+/-2.6%, 13+/-3.1% at the concentration of 0, 0.1, 1.0, 10, 20microgram/ml ganciclovir, respectively. And the survival of HSV-tk not transduced 1x104 neuro 2a cell lines is 100+/-4.5%, 97+/-5.6%, 104+/-3.5%, 106+/-3.8%, 101+/-4.2%. CONCLUSION: We concluded that in vitro transduction of neuroblastoma cell with the herpes simplex-thymidine kinase gene followed by administration of the antiviral drug ganciclovir is very effective.
Animals
;
Cell Line*
;
DNA
;
Ganciclovir
;
Mice
;
Neuroblastoma*
;
Phosphotransferases
;
Retroviridae
;
Zidovudine*
5.Effect of GCV on Neuroblastoma Cell Line Expressed by HSV-TK Gene with Retroviral Vector.
Hyun Sang CHO ; Chuhl Joo LYU ; Yeun Soo KIM ; Tae Soo KIM ; Byung Soo KIM
Journal of the Korean Pediatric Society 1997;40(12):1719-1724
Background : Gene transfer with vectors derived from murine retroviruses is restricted to cells which are proliferating and synthesizing DNA at the time of infection. Accordingly, selective introduction of genes encoding for susceptibility to otherwise nontoxic drugs (suicide genes) into proliferating tumor may be used to treat cancer. We investigated the efficacy of in vitro transduction of neuroblastoma cell with the herpes simplex-thymidine kinase (HSV-tk) gene followed by administration of the antiviral drug ganciclovir. METHODS: The LNC/tK vector was transfered in vitro into mouse Neuro 2a cell lines (ATCC) and the transduced cell lines were selected in G-418, 500microgram/ml, for 14 days. Onex104 cells were cultured in 96 well culture plates in increasing concentrations of ganciclovir for 72 hours. The sesitivity to ganciclivir of these HSV-tk transduced, G-418 selected cells was measured with MTT assay RESULTS: The survival of HSV-tk transduced 1x104 neuro 2a cell lines is 103+/-3.5%, 68+/-4.2%, 54+/-3.8%, 17+/-2.6%, 13+/-3.1% at the concentration of 0, 0.1, 1.0, 10, 20microgram/ml ganciclovir, respectively. And the survival of HSV-tk not transduced 1x104 neuro 2a cell lines is 100+/-4.5%, 97+/-5.6%, 104+/-3.5%, 106+/-3.8%, 101+/-4.2%. CONCLUSION: We concluded that in vitro transduction of neuroblastoma cell with the herpes simplex-thymidine kinase gene followed by administration of the antiviral drug ganciclovir is very effective.
Animals
;
Cell Line*
;
DNA
;
Ganciclovir
;
Mice
;
Neuroblastoma*
;
Phosphotransferases
;
Retroviridae
;
Zidovudine*
6.Detection of resistance mutation to lamivudine in HIV-1 infected patients.
Young Keol CHO ; Heung Sup SUNG ; Hee Jung LEE ; Yoo Kyum KIM ; Hyun Sook CHI ; Goon Jae CHO ; Moon Won KANG
Journal of the Korean Society for Microbiology 2000;35(2):181-190
To investigate resistance to lamivudine (3TC), we examined the incidence of M184V in 20 HIV-1 patients treated with 3TC for 13.1 +/- 9 months. Fourteen of 20 patients had been exposed to zidovudine (ZDV) or didanosine (ddl) prior to 3TC therapy. Nested PCR targeting to reverse transcriptase (RT) and direct sequencing were performed for peripheral blood mononuclear cells sampled serially. There were resistance mutations to ZDV in at least 9 patients at baseline, although there was no resistance mutation to 3TC. We could detect M184V in 6 (30%) out of 20 patients. The incidence of M184V increased as the duration of therapy prolongs (13% in samples<12 months; 47% in samples gtoreq 12 months). The frequency of mutation M184V was higher in patients with previous mutation to ZDV than in patients with wild type. Resistance mutation was not detected in 7 patients. This study shows that resistance to 3TC tends to develop rapidly in patients with baseline mutations or two drugs combination therapy than in those treated simultaneously with triple drugs. This report is the first on resistance to 3TC in Korean AIDS patients.
Didanosine
;
HIV-1*
;
Humans
;
Incidence
;
Lamivudine*
;
Polymerase Chain Reaction
;
RNA-Directed DNA Polymerase
;
Zidovudine
7.Molecular Approaches for Brain Tumor Therapy;Gene Transfer and Anti-sense Oligonucleotides.
Journal of Korean Neurosurgical Society 1996;25(9):1815-1819
Despite advances in neurosurgery, radiation, and chemotherapy, the prognosis of patients with malignant brain tumors still remains grim. Considerable efforts have been made to develop new therapeutic strategies for malignant brain tumors. One of the promising new therapies for brain tumors is an intervention at molecular level, and several molecular approaches have been shown to have in vitro and in vivo activities. These include the use of retroviral vectors, herpes simplex viruses, adenoviral vectors in gene transfer, and antisense vectors and oligonucleotides. Preclinical studies of retroviral vector have already been extended to clinical trials, clearly demonstrating the clinical potential of these molecular therapies. Here, I discuss the current status of molecular therapy for brain tumors together with future directions for its development.
Brain Neoplasms*
;
Brain*
;
Drug Therapy
;
Humans
;
Neurosurgery
;
Oligonucleotides
;
Oligonucleotides, Antisense*
;
Prognosis
;
Simplexvirus
;
Zidovudine
8.Distribution Change of WD40 Repeat Protein 1 in Artificially Induced Senescent PC12 Cells.
Dong Hoon SHIN ; Chang Seok OH ; Eunju LEE ; Seung Ha OH ; Young Soo LEE
Journal of the Korean Geriatrics Society 2006;10(4):285-289
Background: WDR1 is thought to be correlating with polymerization and depolymerization of actin protein. Though WDR1 was found to be within nucleus, in which actin could not be present by previous studies, the exact distribution pattern of WDR1 protein under various circumstances was not elucidated up to the present time. In this regard, we tried to see a change in the distribution of WDR1 protein within artificially induced senescent PC 12 pheochromocytoma cells for the first time. Methods: PC12 pheochromocytoma cells (ATCC CRL-1721) were grown in the culture media including 1 micrometer 3'-Azido-3'-deoxythymidine (AZT, Sigma-Aldrich, USA). The senescence of the cells was confirmed by senescence detection kit (Calbiochem, San Diego, CA). Immunocytochemical study by using WDR1 antibody was also performed in the cells treated with AZT during 0, 75 and 153 days. Results: WDR1 protein was mainly observed within the cytoplasm of the cells not treated with AZT. However, the distribution of the same protein was changed into the nucleus after 153 day-AZT treatment. Conclusion: The distribution of WDR1 protein was changed into nucleus in the artificially senescent PC12 cells.
Actins
;
Aging
;
Animals
;
Culture Media
;
Cytoplasm
;
PC12 Cells*
;
Pheochromocytoma
;
Polymerization
;
Polymers
;
Zidovudine
9.Subcellular Distribution of Microtubule in Artificially Induced Senescent PC12 Cells.
Eunju LEE ; Chang Seok OH ; Dong Hoon SHIN ; Young Soo LEE
Journal of the Korean Geriatrics Society 2006;10(4):278-284
Background: Since recent reports showed the possibility that cytoskeletal proteins, which were known to be exclusively within the cytoplasm, might play a role in the re-distribution of the intranuclear chromatin in a certain type of the cells under specific circumstances, we tried to show a change in the intracellular distribution of microtubule protein in artificially induced senescent PC12 pheochromocytoma cells. Methods: PC12 pheochromocytoma cells (ATCC CRL-1721) were grown in the culture media including 1 micrometer 3'-Azido-3'-deoxythymidine (AZT, Sigma-Aldrich, USA). The senescence of the cells was confirmed by senescence detection kit (Calbiochem, San Diego, CA). Immunocytochemical study was also performed in the cells treated with AZT during 0, 75 and 153 days. Results: beta-tubuline was not observed in the cells not treated with AZT. The same protein was localized within the nuclei in the senescent cells treated with AZT during 153 days. Conclusion: Microtubule might be involved in some crucial roles in the redistribution of chromatin within the nuclei of the senescent cells.
Aging
;
Animals
;
Cell Aging
;
Chromatin
;
Culture Media
;
Cytoplasm
;
Cytoskeletal Proteins
;
Microtubules*
;
PC12 Cells*
;
Pheochromocytoma
;
Tubulin
;
Zidovudine
10.Study on the Zidovudine Resistance of HIV-1 Isolated Strains in Korea.
Jeong Gu NAM ; Chun KANG ; Joo Shil LEE ; Hong Rae LEE ; Dong Yun SHIN ; Yong Keun PARK ; Yung Oh SHIN
Journal of the Korean Society of Virology 1997;27(1):77-86
To examine AZT resistance of HIV-1 isolates from AZT treated or untreated Korean, several biological characteristics such as syncytium formation, HIV-1 reverse transcriptase activity and the p24 antigen production in MT-2 cells infected with 4 HRT_1 isolates were determined. As controls, we tested HIV-1 HTLV-IIIB and pre-drug isolate as AZT susceptible strains, in addition to HIV-1 RTMC/MT-2 and post-drug isolate as AZT resistant strains. When the inoculum size of HIV-1 was 300 TCID50well and 100 TCID50/well, the AZT susceptibility of AZT untreated HIV-1 isolates 8806 and 9571 were similar to that of HIV-1 HTLV-IIIB and AZT-susceptible HIV-1 strains. When we evaluated AZT resistance of isolates HRs-1 8812 and 9113 treated with AZT for 36 months by observation of syncytium formation, HIV-1 8812 showed resistance simillar to that of HIV-1 RTMC/MT-2 strain forming syncytium up to AZT 1microgram/ml, and HIV-1 9113 showed resistance identical with that of AZT-resistant HIV-1 strain which formed syncytium up to AZT 10 microgram/ml. Especially, when we evaluated AZT resistance by HIV-1 reverse transcriptase activty and the p24 antigen production, HIV-1 isolates 8812 and 9113 showed much higher resistance (>10 - 200 fold) compared with HN-1 RTMC/MT-2 and AZT-resistant HIV-1 strain.
Giant Cells
;
HIV-1*
;
Korea*
;
Population Characteristics
;
RNA-Directed DNA Polymerase
;
Zidovudine*